Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Paul Little a Community Clinical Sciences
(Primary Medical Care Group), University of Southampton, Aldermoor
Health Centre, Southampton SO15 6ST, b Three Swans Surgery,
Salisbury, Wiltshire SP1 1DX, c Nightingale Surgery,
Romsey, Hampshire SO51 7QN Correspondence to: P
Little psl3{at}soton.ac.uk
| |
Abstract |
|---|
|
|
|---|
Objectives:
To identify which children with acute
otitis media are at risk of poor outcome and to assess benefit from
antibiotics in these children.
Design:
Secondary analysis of randomised controlled trial cohort.
Setting:
Primary care.
Participants:
315 children aged 6 months to 10 years.
Intervention:
Immediate or delayed (taken after 72 hours if necessary) antibiotics.
Main outcome measure:
Predictors of short term
outcome: an episode of distress or night disturbance three days after
child saw doctor.
Results:
Distress by day three was more likely in
children with high temperature (adjusted odds ratio 4.5, 95%
confidence interval 2.3 to 9.0), vomiting (2.6,1.3 to 5.0), and cough
(2.0, 1.1 to 3.8) on day one. Night disturbance by day three was more likely with high temperature 2.4 (1.2 to 4.8), vomiting (2.1,1.1 to
4.0), cough (2.3,1.3 to 4.2), and ear discharge (2.1, 1.2 to 3.9).
Among the children with high temperature or vomiting, distress by day
three was less likely with immediate antibiotics (32% for immediate
v 53% for delayed,
2=4.0; P=0.045, number
needed to treat 5) as was night disturbance (26% v 59%,
2=9.3; P=0.002; number needed to treat 3). In children
without higher temperature or vomiting, immediate antibiotics made
little difference to distress by day three (15% v 19%,
2=0.74; P=0.39) or night disturbance (20%
v 27%,
2=1.6; P=0.20). Addition of cough
did not significantly improve prediction of benefit.
Conclusion:
In children with otitis media but without fever and vomiting antibiotic treatment has little benefit and a poor
outcome is unlikely.
|
What is already known on this topic
It is unclear which children are more likely to benefit from antibiotics and which features predict poor outcome What this study adds
Children with high temperature or vomiting were more likely to benefit from antibiotics, although it is still reasonable to wait 24-48 hours as many children will settle anyway Children without high temperature or vomiting were unlikely to have poor outcome and unlikely to benefit from immediate antibiotics |
| |
Introduction |
|---|
|
|
|---|
Although otitis media is one of the most common acute respiratory conditions managed in primary care, its treatment is controversial.1-3 Most children will be prescribed antibiotics, but systematic review suggests that there is only marginal benefit.4
We determined the predictors of outcome from a randomised trial in
primary care and assessed whether these predictors identify those
children who are likely to benefit from immediate antibiotics.
| |
Methods |
|---|
|
|
|---|
This study was part of a pragmatic randomised controlled trial of two prescribing strategies for acute otitis media.5
Sample
The participants were children aged 6 months to 10 years who were
brought to their general practitioner with acute otalgia and otoscopic
evidence of acute inflammation (dullness, cloudiness, erythema or
bulging, perforation).
Exclusion criteria were otoscopic appearance consistent with crying or fever alone (pink drum); appearance and history more suggestive of otitis media with effusion and chronic suppurative otitis media; serious chronic disease; use of antibiotics for ear infections within the previous two weeks; previous complications (septic complications, hearing impairment); child too unwell to be left to wait and see (very unwell systemically with high fever, floppy, drowsy, not responding to antipyretics).
Intervention
Children were randomised to immediate antibiotics (amoxicillin or
erythromycin for those allergic to penicillin) or delayed antibiotics.
In the delayed antibiotics group parents were asked to wait for 72 hours after seeing the doctors before considering using the
prescription. They were advised to use antibiotics if their child had
severe otalgia or fever after 72 hours or if discharge lasted for 10 days or more. We used standardised advice sheets to maximise the
support and placebo effect for each strategy and to ensure some
consistency between groups, despite the personal prescribing preference
of the doctor.5-7
Outcome measurement
The general practitioners recorded days of illness, physical
signs, and antibiotic prescription. Parents used daily diaries to
record the children's symptoms (earache, unwell, sleep disturbance),
perceived severity of pain (from 1 (no pain) to 10 (extreme pain)),
number of episodes of distress, number of 5 ml doses of paracetamol
used, and temperature and presence of cough, vomiting, rash, and diarrhoea.
Analysis
We assessed predictors of poor outcome using logistic regression.
We then entered variables that were significant in univariate analysis
at the 5% level by forward selection, starting with the most
significant first, and retained those that remained significant at the
5% level. We then used variables that predicted poor outcome to
identify clinical subgroups, estimated the effect of antibiotic in
those subgroups, and summarised the effect by the number needed to treat.
| |
Results |
|---|
|
|
|---|
Symptom duration was documented in 285 children (90%). There were no differences in clinical characteristics between non-responders and responders.5
Predictors of poor outcome
Predictors of earache lasting for more than three days were ear
discharge (adjusted odds ratio 2.6, 95% confidence interval 1.4 to
4.7), three or more previous courses of antibiotics compared with none
(0.2, 0.1 to 0.5), and moderate compared with extreme satisfaction with
the consultation (3.0, 1.3 to 7.1). However for children whose symptoms
lasted over 72 hours earache was mostly mild (mean score 2.6), and
interviews with parents suggested the outcomes that matter more to them
are night time disturbance and episodes of distress.
Distress by day three was predicted by higher temperature (>37.5°C) recorded by parents on day one (4.5, 2.3 to 9.0), parental reporting of vomiting (2.6, 1.3 to 5.0), and cough (2.0, 1.1 to 3.8). Although prescription of antibiotics may confound these associations, this is unlikely as we have shown that randomisation group did not predict distress.5 Furthermore when we added randomisation group to the logistic model predicting distress, the estimates of all the predictive variables changed by less than 10% (odds ratios were 4.9 for temperature, 2.3 for vomiting, 2.1 for cough).
Night disturbance by day three was predicted by higher temperature recorded on day one (2.4, 1.2 to 4.8), vomiting (2.1, 1.1 to 4.0), cough (2.3, 1.3 to 4.2), and ear discharge (2.1, 1.2 to 3.9).
Benefit of immediate antibiotics
Children with a high temperature or vomiting were more
likely to have poor outcomes by day three (table 1). These children
represent the simplest way to target antibiotics for clinicians and are
a small minority. Immediate antibiotics resulted in less distress,
fewer disturbed nights, and fewer days of crying. Children without
higher temperature or vomiting on day one showed less benefit from
immediate antibiotics (table 2). Cough also predicted distress and
night disturbance by day three. Thus a simple alternative to targeting
those with high temperature or vomiting could be to target children
with two of the three symptoms: high temperature, vomiting, and cough.
However, addition of cough to the symptom count made little difference to the ability to predict benefit from immediate
antibiotics.
|
|
| |
Discussion |
|---|
|
|
|---|
Using data from a randomised controlled trial we found that children with a raised temperature and vomiting were more likely to be distressed or have disturbed nights three days after seeing the doctor and more likely to benefit from immediate antibiotic prescription.
Study limitations
We chose an open trial design and minimally intrusive outcomes
(for example, no intrusive measures of compliance or investigation) to
assess realistic outcomes after pragmatic prescribing strategies in
everyday practice. However, this has the disadvantage of a potential
placebo effect. Although the structured advice sheet approach that we
used has been shown to reduce the placebo effect,6 a
component of this effect may contribute to the apparent benefits from
antibiotics. Any effect, however, was probably small: parental
satisfaction with management did not predict distress and night
disturbance, and adjustment for satisfaction or randomisation group did
not did not confound the estimates nor alter the inferences.
Furthermore the estimates from this study (for example, night
disturbance, consumption of paracetamol)5 were similar to
those in the previous largest placebo controlled trial in primary care
in a similar study population.8 As these data are based on
secondary analysis, however, they require cautious interpretation.
Conclusions
Parents are most concerned about symptoms such as distress and
night disturbance, both of which were predicted by systemic features
(high temperature, vomiting) and cough.
The simplest method to target the minority of children at higher risk
of poor outcome is to select those children with systemic features
that is, either high temperature or vomiting. This identifies children who are likely to benefit. Children without systemic features
are unlikely to benefit from antibiotics. Whether it is worth treating
children with systemic features immediately is debatable as many such
children (about half) will still settle within 72 hours. Nevertheless,
the results support doctors discussing the likely benefit of
antibiotics in systemically unwell children and possibly shortening the
delay period from 72 hours to 48 or 24 hours.
| |
Acknowledgments |
|---|
We are grateful to the following doctors for their enthusiasm and help in recruitment: Drs Newman, Taylor, Traynor, Tippett, Warner, Peace, Stephens, Glasspool, Stone, Webb, Snell, Devereux, Hoghton, Terry, Dickson, Nightingale, Richenbach, Bacon, Lupton, Padday, Cookson, Stanger, Glaysher, Bond, Baker, Barnsley, Jeffries, Willard, Carlisle, Hill, Collier, Cubitt, De Quincey, Over, White, Billington, Percival, Hollands, Glaysher, Stranger.
Contributors: See bmj.com
| |
Footnotes |
|---|
Funding: PL is supported by the MRC.
Competing interests: PL has received fees from Abbott Pharmaceuticals for two consultancy meetings.
The full version of this article
appears on bmj.com
| |
References |
|---|
|
|
|---|
| 1. | Bain J. Childhood otalgia: acute otitis media. 2. Justification for antibiotic use in general practice. BMJ 1990; 300: 1006-1007. |
| 2. | Browning G. Childhood otalgia: acute otitis media. 1. Antibiotics not necessary in most cases. BMJ 1990; 300: 1005-1006. |
| 3. |
Froom J, Culpepper L, Jacobs M, DeMelker RA, Green LA, van Buchem L, et al.
Antimicrobials for acute otitis media? A review from the international primary care network.
BMJ
1997;
315:
98-102 |
| 4. | Glasziou P, Del Mar C, Sanders S, Hayem M. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2002;(1):CD000219. |
| 5. |
Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J.
Pragmatic randomised controlled trial of two prescribing strategies for acute otitis media.
BMJ
2001;
322:
336-342 |
| 6. |
Little PS, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL.
Open randomised trial of prescribing strategies in managing sore throat.
BMJ
1997;
314:
722-727 |
| 7. |
Little PS, Gould C, Williamson I, Warner G, Gantley M, Kinmonth AL.
Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics.
BMJ
1997;
315:
350-352 |
| 8. |
Burke P, Bain J, Robinson D, Dunleavey J.
Acute red ear in children: controlled trial of non-antibiotic treatment in general practice.
BMJ
1991;
303:
558-562 |
(Accepted 15 January 2002)
Chris Del Mar Centre for General
Practice, University of Queensland Medical School, Herston, Queensland
4006, Australia
Correspondence to: C.Delmar{at}CGP.uq.edu.au
Some children are greatly troubled with acute otitis media;
others are hardly inconvenienced. This useful subgroup analysis predicts which children benefit most from antibiotics for acute otitis
media (mostly those with a temperature >37.5°C or vomiting; about
one in five affected children) and the size of the benefit (the number
of children we need to treat to shorten the illness is as high as three
to six). So we still need to weigh potential benefits against costs,
case by case, mixing parental preference and other relevant clinical
and psychosocial information into the clinical decision.
General practitioners may worry about withholding antibiotics because
of past indoctrination with deductive pathophysiology ("the pain of
otitis media is caused by infection in the middle ear, the causative
agents are susceptible to the following antibiotics . . ."). The empirical evidence, however, is that
antibiotics make little difference. They may also worry about the risk
of dangerous suppurative complications. Should another study be
undertaken to address this? There are so few cases of acute
mastoiditis, the most common complication, that such an analysis would
require huge numbers. Data from a large observational study of 4860 cases of acute otitis media showed that initially withholding
antibiotics from those without severe symptoms led to no extra cases of
mastoiditis.1
Could this study be the end of the story? We don't think so.
Firstly, there remain problems with the outcomes measured. We are
interested in two vectors of illness in spontaneously remitting illness: the duration of illness (which Little et al measured) and its
severity. Severity is harder to measure. Together severity and duration
give a measure of "severity days" that more accurately describes
the impact of the illness. Measuring changes on just one axis will
considerably underestimate the effect of an intervention on the burden
of illness. Future research should collect serial data on severity to
estimate changes in "total illness."2
Secondly, for trials of a new intervention the control is usually
nothing (placebo). But for trials of antibiotics for acute respiratory
infections the established treatment is already antibiotics. These then
are trials of "no antibiotics" (the "new" intervention) against
"antibiotics." Therefore patients recruited are likely to be the
least ill. Re-examining the trials in a Cochrane review3 we could extract this "non-recruitment because the child was too ill" out of the total recruited from only two of the seven trials (52/232 and 27/240). We need a greater understanding of how selection of patients for trials may affect the interpretation and application of results.
We also have surprisingly little information about alternative
treatments. With spontaneously remitting illnesses such as acute otitis
media, killing bacteria ("cure") has no advantage over palliating
the symptoms.2 We know that antihistamines and
decongestants contribute modest, if any, benefit.4 But which is the best analgesic? Is anything else helpful? Innovative emerging treatments, such as using benign commensals to overwhelm pathological bacteria, may ultimately prove the most effective treatment for acute otitis media5 and make the current
debate over antibiotic use redundant.
![]()
Footnotes
![]()
References
1.
Van Buchem FL, Peeters MF, van't Hof MA.
Acute otitis media: a new treatment strategy.
BMJ
1985;
290:
1033-1037 2.
Del Mar C.
Spontaneously remitting disease. Principles of management.
Med J Aust
1992;
157:
101-107.
3.
Glasziou PP, Del Mar CB, Hayem M, Sanders SL. Antibiotics for
acute otitis media in children. Cochrane Database Syst
Rev 2002;(1):CD000219.
4.
Flynn CA, Griffin G, Tudiver F. Decongestants and
antihistamines for acute otitis media in children. Cochrane
Database Syst Rev 2002;(1):CD001727.
5.
Roos K, Håkansson EG, Holm S.
Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial.
BMJ
2001;
322:
1-4.
© BMJ 2002
Read all Rapid Responses